Chapter Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety
This chapter aims to describe current and emerging roles of spontaneous reporting systems (SRSs) for assessing and monitoring drug safety. Moreover, it offers a perspective on the near future, which entails the so-called era of Big Data, keeping in mind both regulator and researcher viewpoints. Afte...
Saved in:
Main Author: | |
---|---|
Other Authors: | , , , , , |
Format: | Electronic Book Chapter |
Language: | English |
Published: |
InTechOpen
2019
|
Subjects: | |
Online Access: | OAPEN Library: download the publication OAPEN Library: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | oapen_2024_20_500_12657_49320 | ||
005 | 20210602 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20210602s2019 xx |||||o ||| 0|eng d | ||
020 | |a intechopen.79986 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.5772/intechopen.79986 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a MBN |2 bicssc | |
100 | 1 | |a Cosimo Antonazzo, Ippazio |4 auth | |
700 | 1 | |a Salvo, Francesco |4 auth | |
700 | 1 | |a Raschi, Emanuel |4 auth | |
700 | 1 | |a Pariente, Antoine |4 auth | |
700 | 1 | |a Moretti, Ugo |4 auth | |
700 | 1 | |a Poluzzi, Elisabetta |4 auth | |
700 | 1 | |a De Ponti, Fabrizio |4 auth | |
245 | 1 | 0 | |a Chapter Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety |
260 | |b InTechOpen |c 2019 | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a This chapter aims to describe current and emerging roles of spontaneous reporting systems (SRSs) for assessing and monitoring drug safety. Moreover, it offers a perspective on the near future, which entails the so-called era of Big Data, keeping in mind both regulator and researcher viewpoints. After a panorama on key data sources and analyses of post-marketing data of adverse drug reactions, a critical appraisal of methodological issues and debated future applications of SRSs will be presented, including the exploitation and challenges in evidence integration (i.e., merging and combining heterogeneous sources of data into a unique indicator of risk) and patient's reporting via social media. Finally, a call for a responsible use of these studies is offered, with a proposal on a set of minimum requirements to assess the quality of disproportionality analysis in terms of study conception, performing and reporting. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
546 | |a English | ||
650 | 7 | |a Public health & preventive medicine |2 bicssc | |
653 | |a pharmacovigilance, signal, spontaneous reporting system, disproportionality analysis | ||
773 | 1 | 0 | |7 nnaa |
856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/bitstream/id/ba0a123c-9073-4a1a-bd62-441fcb15cb76/63595.pdf |7 0 |z OAPEN Library: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://library.oapen.org/handle/20.500.12657/49320 |7 0 |z OAPEN Library: description of the publication |